Trigger Point Injection: A Therapeutic Propellant for Myofascial Pain Syndromes

Area of Science:

• Pain Management
• Musculoskeletal Disorders
• Regenerative Medicine

Background:

• Myofascial pain syndromes (MPS) are a frequent cause of pain, originating from muscle trigger points.
• Current curative methods for MPS are limited, making trigger point injection therapy a popular clinical option.
• The optimal injectable substance for trigger point injection therapy remains debated.

Purpose of the Study:

• To review clinical research progress on trigger point injection therapy for MPS.
• To evaluate the efficacy of various injectable drugs used in trigger point injections.
• To outline precautions for drug administration in MPS management.

Main Methods:

• Literature review of clinical studies on trigger point injection therapy.
• Analysis of drug efficacy and safety profiles for MPS treatment.
• Synthesis of current knowledge on managing myofascial pain syndrome.

Main Results:

• Trigger point injection therapy is a low-cost, minimally invasive approach with promising early results.
• Various injectable substances, including local anesthetics, steroids, and platelet-rich plasma, are used.
• Lack of consensus on the best injectable agent poses a clinical challenge.

Conclusions:

• Trigger point injection therapy is a viable option for myofascial pain syndrome.
• Further research is needed to establish optimal injectable substances and protocols.
• This review provides a foundation for future studies and clinical practice in MPS management.